A randomized, single dose, 2-way crossover, open study in healthy male volunteers to evaluate the pharmacokinetics and the safety of CDFF0212 and Aricept Evess tablet 10 mg

Trial Profile

A randomized, single dose, 2-way crossover, open study in healthy male volunteers to evaluate the pharmacokinetics and the safety of CDFF0212 and Aricept Evess tablet 10 mg

Completed
Phase of Trial: Phase I

Latest Information Update: 31 May 2017

At a glance

  • Drugs Donepezil (Primary)
  • Indications Dementia
  • Focus Pharmacokinetics
  • Sponsors CTCBIO
  • Most Recent Events

    • 08 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top